Related Experiment Videos
Neurological involvement in hereditary transcobalamin II deficiency
Journal of Neurology, Neurosurgery, and Psychiatry
|January 1, 1982
Summary
Hereditary transcobalamin II deficiency can cause severe neurological deficits in infants, even with early treatment. Prompt diagnosis and hydroxocobalamin are crucial for managing this rare genetic disorder.
Area of Science:
- Pediatric Neurology
- Clinical Genetics
- Nutritional Biochemistry
Background:
- Hereditary transcobalamin II deficiency is a rare genetic disorder affecting vitamin B12 metabolism.
- Early diagnosis and intervention are critical for preventing severe health complications.
Observation:
- A case study details an infant presenting with megaloblastic anemia and delayed diagnosis of transcobalamin II deficiency.
- The patient exhibited significant intellectual disability, ataxia, and pyramidal deficits by age two.
- Initial treatment with folinic acid was insufficient; hydroxocobalamin was administered after diagnosis.
Findings:
- Delayed diagnosis of transcobalamin II deficiency led to irreversible severe neurological deficits.
- Hydroxocobalamin treatment showed slow improvement but did not fully reverse the neurological damage.
- This case highlights the critical window for intervention in vitamin B12 deficiency impacting infant neurological development.
Implications:
- Emphasizes the importance of early screening for inborn errors of metabolism, including transcobalamin II deficiency.
- Underscores the profound and potentially permanent impact of vitamin B12 deficiency on infant brain development.
- Suggests a need for increased awareness among clinicians regarding the neurological manifestations of hereditary transcobalamin II deficiency.